期刊文献+

165例急性白血病死亡原因回顾 被引量:7

Cause of death in 165 cases of acute leukemia
在线阅读 下载PDF
导出
摘要 目的:分析探讨165例急性白血病(非M3)的死因。方法:回顾165例急性白血病(非M3)死亡病例,总结急性白血病主要死亡原因及死亡时的疾病状态。结果:116例急性非淋巴细胞性白血病(非M3)的主要死因为感染(45.7%)和出血(28.4%),其次为中枢神经系统(8.6%)和肺部弥漫性损害(6.9%),44.0%病例死于疾病的复发阶段,28.4%在发病早期,25.0%在未缓解期内,仅2.6%死于完全缓解阶段。49例急性淋巴细胞性白血病的主要死因为感染(34.7%)、出血(30.6%)和浸润(26.5%),最常见的感染形式为败血症,出血和浸润最易累及的部位分别为颅内和中枢神经系统,多数病例死于疾病的早期(45.0%)和复发阶段(51.0%)。结论:感染、出血和浸润是急性白血病(非M3)的三大主要死因。 Objective To review the causes of death in 165 patients with acute leukemia. Methods The clinical data from 165 patients with acute non-acute promyelocytic leukemia (APL) were retrospectively analysed. The major causes of death and the status of disease at death were summarized. Results The most common causes of death in 116 acute non-APL leukemia were infection(45.7%), hemorrhage(28.4%), diffused lung damage (6.9%) and central nervous system infiltration(8.6%). The most common stage at death was relapse stage (44.0%), followed by early stage (28.4%), non-remission stage (25.0%) and complete remission stage (2.6%). Concurrently, the most common causes of death in 49 acute lymphocytic leukemia were infection (34.7%), hemorrhage(30.6%) and infiltration(26.5%). The most common type of infection and hemorrhage was septicemia and intra-cranial bleeding, respectively. The central nervous system was the most easy-to-be-involved infiltration site. The most common stage at death was early stage (45.0%), followed by relapse stage (51.0%). Conclusions Infection, hemorrhage and infiltration are the three major causes of death in acute non-APL.
出处 《内科理论与实践》 2007年第1期30-33,共4页 Journal of Internal Medicine Concepts & Practice
关键词 急性白血病 死因分析 感染 Acute leukemia Cause of death Infection
  • 相关文献

参考文献10

  • 1Puga BL,Cabrera ME,Undurraga MS,et al.Acute myeloid leukemia in the adult Results of the National Antineoplastic Drug Protocol at the Hospital del Sal-vador,1990-1998[].Rev Med Chil.2000
  • 2Funai N,,Shimamoto Y,Tokunaga O,et al.Ten-year survey of incidence of infection as a cause of death in hematologic malignancies:study of90autopsied cases[].Acta Haematologica.1995
  • 3Kantarjian HM,O′Brien S,Smith TL,et al.Results of treatment with hyper-CVAD,a dose-intensive regimen,in adult acute lymphocytic leukemia[].Journal of Clinical Oncology.2000
  • 4Estey E.Reducing mortality associated with immediate treatment complications of adult leukemias[].Seminars in Hematology.2001
  • 5Annino L,,Vegna ML,Camera A,et al.Treatment of adult acute lymphoblastic leukemia(ALL):long-term follow-up of the GIMEMA ALL0288randomized study[].Blood.2002
  • 6Stalfelt AM.A"good death"needs to be discussed.A study of patients with acute myeloid leukemia demon-strates the value of palliative care[].Lakartidningen.2003
  • 7Dekker AW,van′t Veer MB,van der Holt B,et al.Postremission treatment with autologous stem cell trans-plantation(Auto-SCT)or allogeneic stem cell transplanta-tion(Allo-SCT)in adults with acute lymphoblastic leukemia(ALL) A phase II clinical trial(HOVON18ALL)[].Blood.2001
  • 8Bassan R,Pogliani E,Casula P,et al.Risk-oriented postremission strategies in adult acute lymphoblastic leukemia:prospective confirmation of anthracycline activity in standard-risk class and role of hematopoietic stem cell transplants in high-risk groups[].Hematol Journal.2001
  • 9Latagliata R,Petti MC,Mandelli F.Acute myeloid leukemia in the elderly:‘per aspera ad astra’?[].Leukemia Research.1999
  • 10Hiddemann W,Kern W,Schach C,et al.Management of acute myeloid leukemia in elderly patients[].Journal of Clinical Oncology.1999

同被引文献34

引证文献7

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部